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Electrocardiographic Repolarization-Related Variables as Predictors
of Coronary Heart Disease Death in the Women’s Health Initiative
Study
Pentti M. Rautaharju, MD, PHD; Zhu-Ming Zhang, MD; Mara Vitolins, PhD; Marco Perez, MD; Matthew A. Allison, MD, MPH;
Philip Greenland, MD; Elsayed Z. Soliman, MD, MSc, MS
Background-—We evaluated 25 repolarization-related ECG variables for the risk of coronary heart disease (CHD) death in 52 994
postmenopausal women from the Women’s Health Initiative study.
Methods and Results-—Hazard ratios from Cox regression were computed for subgroups of women with and without
cardiovascular disease (CVD). During the average follow-up of 16.9 years, 941 CHD deaths occurred. Based on electrophys-
iological considerations, 2 sets of ECG variables with low correlations were considered as candidates for independent predictors of
CHD death: Set 1, Ѳ(Tp|Tref), the spatial angle between T peak (Tp) and normal T reference (Tref) vectors; Ѳ(Tinit|Tterm), the angle
between the initial and terminal T vectors; STJ depression in V6 and rate-adjusted QTp interval (QTpa); and Set 2, TaVR and TV1
amplitudes, heart rate, and QRS duration. Strong independent predictors with over 2-fold increased risk for CHD death in women
with and without CVD were Ѳ(Tp|Tref) >42° from Set 1 and TaVR amplitude >100 lV from Set 2. The risk for these CHD death
predictors remained significant after multivariable adjustment for demographic/clinical factors. Other significant predictors for
CHD death in fully adjusted risk models were Ѳ(Tinit|Tterm) >30°, TV1 >175 lV, and QRS duration >100 ms.
Conclusions-—Ѳ(Tp|Tref) angle and TaVR amplitude are associated with CHD mortality in postmenopausal women. The use of these
measures to identify high-risk women for further diagnostic evaluation or more intense preventive intervention warrants further
study.
Clinical Trial Registration-—URL: http://www.clinicaltrials.gov. Unique identifier: NCT00000611. ( J Am Heart Assoc. 2014;3:
e001005 doi: 10.1161/JAHA.114.001005)
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E lectrocardiographic depolarization- and repolarization-related abnormalities as predictors of coronary heart
disease (CHD) mortality and morbidity have been a
subject of many electrocardiographic investigations. From
repolarization-related abnormalities, QT prolongation has
been a common topic in studies on general populations and
in clinical study groups, particularly with cardiovascular
disease (CVD).1 Some newer reports from general popula-
tions have documented increased risk for CHD death for
widened spatial angle between mean QRS and ST-T vectors
(Ѳ(QRS|STT)).2,3 ST- and T-wave findings in women with
CVD are generally considered as secondary abnormalities of
little importance in clinical ECG interpretation, although
some studies have associated them with CHD mortality
risk,4–7 including the risk of sudden cardiac death (SCD).
From depolarization-related ECG abnormalities, QRS dura-
tion increase even within its upper normal range has been
found to be an independent predictor of CHD death,
including SCD.4,8,9
A recently developed repolarization model introduced
several novel repolarization-related variables from various
repolarization time (RT) subintervals such as QT peak (QTp)
interval, epicardial repolarization time (RTepi), left ventri-
cular crossmural RT gradient (XMRTgrad) and, in addition to
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Ѳ(QRS|STT), several other spatial angles representing devi-
ation of the repolarization sequence from normal direction
during various RT subintervals.3,10–12 The primary objective of
the present study was to evaluate the risk of CHD death for
these novel ECG risk predictors in postmenopausal women
from the Women’s Health Initiative (WHI) study.
Methods
Study Population
The WHI is a 40-center, national study of risk factors and the
prevention of common causes of mortality, morbidity, and
impaired quality of life in women. Postmenopausal women
aged 50 to 79 years from various ethnic groups were
recruited from 1994 to 1998. Details of the study design,
protocol sampling procedures, and selection and exclusion
criteria have been published previously.13 The present study
group consisted of 68 133 women, a subgroup of the clinical
trial component of WHI, which had digital ECGs and compre-
hensive documentation of outcome events available.
Participants with missing or incomplete ECG data (n=966)
were excluded; ECGs with inadequate quality or technical
errors by visual inspection (n=614), bundle branch blocks
(n=1739), electronic pacemakers or WPW pattern (n=109),
and 47 ECGs with heart rate >100/min and 3 ECGs with
incomplete data were also excluded. From the remaining
group of 64 661 participants, 12 569 were found to have had
a CVD event while 52 092 were CVD-free at baseline. The
sequential steps in selection of the study group for risk
analyses are shown in the block diagram in Figure 1.
Protocols for human studies were reviewed and
approved by Institutional Review Boards of each participat-
ing center, and informed consent was obtained from each
participant.
ECG Methods
Standard 12-lead ECGs were recorded in all women in the
supine position using MAC PC electrocardiographs (GE
Marquette, Inc, Milwaukee, WI). ECG technicians in all
participating centers were trained to use carefully standard-
ized procedures for ECG acquisition including locating the
chest electrodes in precise positions using a special chest
electrode locator.14 All electrocardiograms received at a
Central ECG Laboratory (EPICARE Center, University of
Alberta; Edmonton, Alberta, Canada and later at Wake Forest
University, Winston-Salem, NC) were inspected visually to
detect technical errors, missing leads, and inadequate quality,
and such records were rejected from ECG data files. The ECGs
were processed by 2001 version of the Marquette 12SL
program (GE Marquette, Inc, Milwaukee, WI).
Repolarization Parameters from the
Repolarization Model
The orthogonal Frank XYZ leads were obtained from the 8
independent components (leads I, II, V1 to V6) using a
transformation matrix from the 116-lead body surface map
library of Horac^ek containing recordings for 892 adults aged 16
to 85 years.15 Repolarization measurements were made utiliz-
ing temporal reference points derived from the spatial T-vector
magnitude curve derived from the XYZ leads (the “global” T
wave), including QT end (QTe), QTpeak (QTp), and QTonset (QTo)
intervals. QTe, QTp, and QTo intervals were rate adjusted (QTea,
QTpa and QToa, respectively) as linear functions of the RR
interval with the following formulas derived in the CVD-free
group: QTea=QTe+1849(1RR), QTpa=QTp+1359(1RR) and
QToa=QTo+1139(1RR). Heart rate, QRS duration, QRS non-
dipolar voltage from singular value decomposition and a set of
22 repolarization-related ECG variables from our repolarization
model were chosen for evaluation because of their functional
role in generation of normal and abnormal repolarization
Participants eligible (n=68,133)
Excluded 3,422:
No computer ECG (n=960)
Inadequate quality (n=614)
Electronic pacemaker or WPW pattern (n=109)
Bundle branch block (n=1,739)
Heart rate >109 bpm (n=47)
Incomplete data (3)
Participants remaining (n=64,661)
CVD Group (n=12,569)
Sequential exclusions for selection 
of CVD-Free Group:
History of MI, angina, coronary bypass, 
angioplasty, congestive heart failure (n=10108)
ECG-MI (n=1,362 of the remaining )
AF at baseline ECG (n=212 of the remaining)
CV >1,200 microvolts with MC4.1-4.3 
(n=425 of the remaining)
Other MC4.1-4.2 (n=192 of the remaining)
Participants remaining (n=52,092)
CVD-Free Group
Figure 1. A block diagram for exclusions and sequential selec-
tions of the study group. AF indicates atrial brillation; CV, Cornell
Voltage; CVD, cardiovascular disease; MI, myocardial infarction;
WPW, Wolf-Parkinson-White pattern.
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waveforms or because of their previously shown value as risk
predictors.2,3,10–12 QRS duration was included as the second
depolarization-related parameter in addition to QRS nondipolar
voltage from singular value decomposition because even
moderate QRS prolongation is known to induce secondary
repolarization abnormalities, which may be associated with
adverse cardiac events over and above those induced by QRS
prolongation alone.
The conceptual model used to derive RT subintervals and
other model parameters for the present study has been
described in detail in previous publications.2,3,10–12 A simplified
summary description of the main model variables in nonstatis-
tical terms is contained in Table 6. In more basic terms, RT of
the subepicardial myocyte layers (RTepi), 1 of the main
repolarization model parameters, is considered to represent
RT of left ventricular (LV) myocytes at the time of global T-wave
peak (Tp) when the majority of LV lateral wall myocytes are at
some point of phase 3 of their action potential. RTepi is
computed as a function of QTpa whereby RTepi=QTpa(1CosѲ
(Tp|Tref)9(TpTxd))/2, where Ѳ(Tp|Tref) is the spatial angle
between the Tp vector and Tref is the reference normal Tp
vector with xyz components (0.75, 0.57,0.33). TpTxd, in turn,
is the interval from Tp to Txd, where Txd is the inflexion point (the
steepest negative slope) at global T wave downstroke. Thus,
RTepi is obtained from QTpa by modifying it by the degree of
deviation of direction of the initial repolarization from the
direction of normal repolarization. RT at time point Txd (RTxd) is
obtained with an algorithm similar to that for RTepi, whereby
RTxd=QTpa(1+CosѲ(Tp|Tref)9(TpTxd))/2. In addition to Ѳ(Tp|
Tref) noted above, a number of other spatial angles between
various QRS and T vectors and other interval and amplitude
variables were used in various phases of the study.
Ascertainment of Outcome Events
After baseline, deaths and hospitalization events were ascer-
tained in each clinical center by annual follow-up calls, review
of vital records, and community surveillance of hospitalized
and fatal events. Detailed definitions for criteria for CHD
death classification have been published previously.16 Briefly,
CHD deaths included death with no known non-CHD death
and either a history of chest pain within 72 hours before
death or a history of chronic ischemic heart disease in the
absence of valvular heart disease. The average follow-up was
15.9 years (up to 17 years).
Statistical Methods
Frequency distributions of ECG variables from the repolariza-
tion model were first inspected to rule out anomalies and
outliers. QTe distributions were skewed, but otherwise, no
anomalies that would notably interfere with analyses were
observed. ECG predictors were first evaluated individually in
unadjusted single ECG variable models and subsequently
in multivariable-adjusted models adjusted for age, race,
smoking status, diabetes, hypertension, family history of
CHD and stroke, body mass index, hypercholesterolemia, and
study component/arm groups (hormone therapy/dietary
modification/calcium, and vitamin D).
In the search for independent predictors for CHD death, 1
primary concern was the collinearity of variables with high
correlations. A previous investigation in participants free from
cardiovascular disease from the Atherosclerosis Research in
Communities Study found Ѳ(Tp|Tref) and aVR amplitude as
independent predictors of CHD death and SCD.3 These 2
correlated variables (r=0.56) were used as primary explana-
tory variables, and a search was performed separately for
each to identify other variables with low correlations (r<0.4).
This procedure produced 2 sets of predictors as candidates
for independent predictors for CHD death: Set 1, Ѳ(Tp|Tref)
and spatial angle between the initial and terminal T vectors Ѳ
(Tinit|Tterm), respectively), STJ depression in V6, rate-adjusted
QTp interval (QTpa); and Set 2, TaVR and TV1 amplitudes, heart
rate, and QRS duration. An association was considered
significant when the P-value (2-sided) was <0.05.
Consistent with our previous risk data in studies with
different end points,11,12 it was observed that CHD risk in
general started to increase after the 80th percentile of the ECG
variable distribution. Therefore, hazard ratios were constructed
to evaluate the risk for CHD death with quintile 5 as the test
group with quintiles 1 to 4 as the reference group. However, for
ST J point and T-wave amplitudes in aVL and V6, the risk of CVD
death was observed to increase at values below the 20th
percentile of the distribution and quintile 1 was used as the test
group for these variables, with quintiles 2 to 5 as the reference
group. Risk for CHD death was first evaluated using group-
specific cut points for the test group at 80th or 20th percentile.
The quintiles were chosen for evaluation with the expectation
that significant predictors for CHD death in test quintiles would
be strong predictors with higher cut points. Finally, cut points
were set at values representing upper or lower fifth percentiles
of the CVD-free group, and these dichotomized cut points were
used also for the CVD group.
All analyses were performed with SAS version 9.2 (SAS
Institute, Cary, NC).
Results
Characteristics of the Study Population
The subgroup of women considered CVD-free after exclusion
of women with clinical or ECG evidence of any CVD was
relatively healthy (Table 1). Still, 31% were hypertensive or on
antihypertensive medication. All women with ECG-LVH
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(RaVL+SV3 >2200 lV with ST depression including the so-
called LV strain pattern (ECG-LVH with down sloping ST and
negative T wave) had been transferred to the CVD group. Five
percent of the CVD-free women had diabetes, and 0.1% had
atrial fibrillation by self-report. As expected, most differences
between CVD and CVD-free groups were statistically signif-
icant. Nearly one half of the women with CVD were
hypertensive, 11% had diabetes, 20% had atrial fibrillation by
self-report and 1.7% had atrial fibrillation in the baseline ECG.
Approximately one half of women in both groups had never
smoked and about 8% were current smokers.
Single ECG Variables as Predictors of CHD Death
More than one half of the 25 ECG variables evaluated were
significant predictors of CHD death in unadjusted single ECG
variable risk models (not shown) and remained significant
predictors in multivariable adjusted (Table 2). Four ECG
variables in CVD-free women had an over 1.50-fold increased
risk for CHD death. The strongest predictor in CVD-free
women was ToV/TpV (hazard ratios 1.93 [1.42 to 2.63],
P<0.001), the ratio of the spatial magnitudes of T vectors at T
wave onset and T wave peak. Increased value of this variable
reflects reduced convexity of ST magnitude curve which in
turn is thought to reflect triangularization of phase 3 of LV
lateral wall action potentials. Many ECG variables in women
with CVD were strong predictors of CHD death, including ToV/
TpV and STJ-point and T wave amplitudes in several ECG leads.
Twelve of the ECG variables had an over 1.5-fold increased
risk for CHD death, and for 2 of them, Ѳ(Tp|Tref) and STJV6,
there was an over 2-fold increased risk.
Independent ECG Predictors of CHD Death
It was observed that many of the repolarization variables
including several of T wave and STJ-point amplitudes were
correlated with Ѳ(Tp|Tref) (r>0.4) (Table 3). A smaller subset
of variables with lower correlation with Ѳ(Tp|Tref) (r<0.4) were
chosen initially to search for independent predictors for CHD
death. Two sets of predictors were identified as independent
predictors of CHD death (Table 4). Set 1, spatial angles
between T peak (Tp) and normal T reference (Tref) vectors and
between the initial and terminal T vectors (Ѳ(Tp|Tref) and Ѳ
(Tinit|Tterm), respectively), STJ depression in V6; and Set 2,
TaVR and TV1 amplitudes and QRS duration. The strongest
independent predictors in women with and without CVD were
Ѳ(Tp|Tref) >42° in Set 1 and TaVR amplitude less negative
than 100 lV in Set 2 with an over 2-fold increased risk for
both, and also heart rate >84 had an over 2-fold increased
risk among Set 2 variables in CVD-free women. For the other
independent predictors of CHD death in Set 1, risk increase
ranged from 30% for ST J-point amplitude in V6 to 87% for
heart rate and in Set 2 from 56% for TV1 amplitude to 64% for
QRS duration. These independent predictors of CHD death in
multivariable Model 1 remained significant with additional
multivariate adjustment for demographic and clinical fac-
tors in Model 2. It is noteworthy that Set 2 ECG variables
TaVR and heart rate were as strong predictors for the risk of
CHD death as the computationally more complex best Set 1
variable Ѳ(Tp|Tref).
Clinical Diseases and Related ECG Findings as
Predictors of CHD Death
Hazard ratios are listed in Table 5 for selected clinical
classification categories and related ECG findings of interest.
Atrial fibrillation by self-report was the strongest predictor in
the remaining classification categories in CVD-free women,
with an over 4-fold increased risk for CHD death in
multivariable-adjusted model. However, the prevalence of
this condition was low in CVD-free women (0.1%, Table 1).
Table 1. Demographic/Clinical Characteristics* of the Study
Group by CVD Status at Baseline
Characteristics
CVD-Free
(n=52 092)
CVD
(n=12 569)
Age, y 62; 6.9 65; 7.0
Weight, kg 76; 16.5 78; 17.2
Body mass index, kg/m2 28.8; 5.8 29.6; 6.1
Systolic blood pressure, mm Hg 127; 17.0 131; 18.2
Diastolic blood pressure, mm Hg 76; 9.0 76; 9.4
Smoking
Never 51.3 49.9
Past 40.7 41.9
Current 7.9 8.2
Hypertension 30.1 49.6
Diabetes 5.2 10.5
History of AF by self-report 0.1 19.5
ECG-AF at baseline — 1.7
Ectopic ventricular complexes 3.4 5.2
ECG-LVH & major STT† — 2.8
Major ST depression‡ — 8.6
Left atrial enlargementk 4.3 7.5
ECG-MI by MCk — 13.0
P<0.001 for all except P=0.002 for diastolic blood pressure and 0.011 for smoking.
From Student t test for differences between the means or from z test for proportions.
AF indicates atrial fibrillation; CVD, cardiovascular disease; MI, myocardial infarction.
*Mean and SD or %.
†ECG-LVH=left ventricular hypertrophy by Cornell Voltage (RaVL+SV3) ≥2200 lV and ST
depression by Minnesota Code (MC) 4.1 to 4.3.
‡MC 4.1 or 4.2.
kMC 9.6.
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Diabetes was a strong predictor of CHD death, with a 2.7-fold
increased multivariable-adjusted risk in both groups of
women. Hypertension in CVD-free women had a 1.59-fold
multivariable-adjusted increased risk for CHD death and a
1.81-fold increased risk in women with CVD. Of interest is
that ventricular ectopic complexes and left atrial enlargement
Table 2. Single ECG Variable Multivariable-Adjusted Hazard Ratios With 95% CI for CHD Death in Women by CVD Status at
Baseline
ECG Variables
CVD-Free Group CVD Group
Test Quintile Limit* HR (95% CI)† P Value‡ Test Quintile Limit* HR (95% CI)† P Value
Heart rate Q5 >74 1.51 (1.28 to 1.79) <0.001 Q5 >74 1.37 (1.12 to 1.68) 0.0022
QRS duration, ms Q5 >92 1.19 (0.99 to 1.43) 0.0679 Q5 >94 1.39 (1.13 to 1.70) 0.0022
QTea, ms
§ Q5 >425 1.25 (1.07 to 1.49) 0.0077 Q5 >428 1.23 (1.00 to 1.51) 0.0468
QTpa, ms
§ Q5 >354 1.48 (1.25 to 1.74) <0.001 Q5 >358 1.28 (1.04 to 1.58) 0.0181
QToa, ms
§ Q5 >268 1.46 (1.24 to 1.72) <0.001 Q5 >273 1.30 (1.06 to 1.59) 0.0116
TpTxd, ms
‖ Q5 >40 1.05 (0.87 to 1.26) 0.6373 Q5 >42 1.22 (0.99 to 1.50) 0.0618
(TpTe)a, ms¶ Q5 >90 0.89 (0.74 to 1.08) 0.2351 Q5 >92 1.03 (0.83 to 1.29) 0.7786
RTepi, ms
# Q5 >350 1.43 (1.21 to 1.70) <0.001 Q5 >352 0.97 (0.77 to 1.22) 0.8126
RTendo, ms** Q5 >383 1.36 (1.15 to 1.61) 0.0003 Q5 >387 1.14 (0.92 to 1.41) 0.2416
RNDPV, lV†† Q5 >52 1.09 (0.90 to 1.32) 0.3745 Q5 >57 1.41 (1.14 to 1.73) 0.0013
Ѳ(R|STT) (°)‡‡ Q5 >79 1.52 (1.29 to 1.78) <0.001 Q5 >89 1.86 (1.54 to 2.25) <0.001
Ѳ(Tp|Tref) (°)
§§ Q5 >25 1.51 (1.28 to 1.78) <0.001 Q5 >36 2.10 (1.74 to 2.54) <0.001
Ѳ(Tinit|Tterm) (°)
‖‖ Q5 >21 1.44 (1.22 to 1.70) <0.001 Q5 >25 1.70 (1.40 to 2.03) <0.001
STJV, lV¶¶ Q5 >45 1.13 (0.94 to 1.36) 0.1982 Q5 >50 1.61 (1.31 to 1.96) <0.001
ToV, lV
¶¶ Q5 >132 0.95 (0.78 to 1.16) 0.6057 Q5 >128 1.34 (1.09 to 1.66) 0.0066
TpV, lV
¶¶ Q5 >437 0.83 (0.67 to 1.03) 0.0841 Q5 >413 1.06 (0.83 to 1.34) 0.6594
ToV/TpV
## Q5 >0.36 1.93 (1.42 to 2.63) <0.001 Q5 >0.41 1.87 (1.47 to 2.38) <0.001
STJaVR, lV*** Q5 >5 1.37 (1.16 to 1.61) <0.001 Q5 >4 1.64 (1.34 to 1.99) <0.001
STJ aVL, lV*** Q1 <10 1.16 (0.97 to 1.39) 0.1088 Q1 <10 1.33 (1.09 to 1.61) <0.001
STJ V1, lV Q5 >14 1.41 (1.19 to 1.67) <0.001 Q5 >19 1.51 (1.24 to 1.84) <0.001
STJ V6, lV Q1 <0 1.15 (0.97 to 1.37) 0.0979 Q1 <10 2.01 (1.66 to 2.42) <0.001
Tam aVR, lV Q5 >166 1.49 (1.26 to 1.75) <0.001 Q5 >122 1.96 (1.62 to 2.37) <0.001
Tam aVL, lV Q1 <19 1.45 (1.23 to 1.71) <0.001 Q1 <19 1.58 (1.30 to 1.91) <0.001
Tam V1, lV Q5 >83 1.29 (1.09 to 1.52) 0.0033 Q5 >102 1.60 (1.32 to 1.95) <0.001
Tam V6, lV Q1 <41 1.60 (1.36 to 1.88) <0.001 Q1 <87 1.89 (1.56 to 2.29) <0.001
CHD indicates coronary heart disease; CVD, cardiovascular disease; ECG, electrocardiographic; HR, hazard ratio.
*Test group threshold for the quintile (Q) listed with the remaining 4 quintiles as the reference group.
†Single ECG variable model was multivariable-adjusted for study arm, age, race, smoke status, diabetes, hypertension, family history of CHD/stroke, body mass index, and total
cholesterol; ECG variables with low correlations were entered simultaneously into the multiple ECG variable model, adjusting each of them to the other ECG variables and subsequently
multivariable-adjusted to the same set of demographic/clinical variables as the single ECG variable model.
‡P value from Student t test for differences between the means or from z test for proportions.
§QTea, QTpa, and QToa=rate adjusted QTend (QTe), QTpeak (QTp), and QTonset (QTo) whereby QTea=QTe+1849(1RR), QTpa=QTp+1359(1RR), and QToa=QTo+1139(1RR).
‖TpTxd=TpTxd interval representing dispersion of the initial left ventricular lateral wall repolarization time (RT) or crossmural RT gradient.
¶(TpTe)a=global repolarization time dispersion (interval from QTpa to QTea).
#RTepi=ECG estimate of epicardial repolarization time. (see Methods section).
**RTendo=ECG estimate of endocardial repolarization time.
††RNDPV=QRS nondipolar voltage from singular value decomposition (square root of pooled variance of components 4 to 8) repolarization.
‡‡Ѳ(R|STT)=spatial angle between mean QRS and T vectors.
§§Ѳ(Tp|Tref)=spatial angle between Tp vector and the T reference (Tref) vector.
‖‖Ѳ(Tinit|Tterm)=spatial angle between the initial T vectors from quintiles 1 to 3 and the terminal T vectors from quintiles 4 to 5.
¶¶Symbol “V” in STJV, ToV and TpV refers to spatial magnitudes of STJ, To, and Tp vectors.
##ToV/TpV=ratio of ToV and TpV vector magnitudes.
***STJ refers to ST onset (J point) amplitudes in the leads listed.
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were both significant predictors of CHD risk in both groups of
women.
Discussion
Key results of this investigation can be summarized as
follows: (1) A majority of the ECG variables were significant
predictors of CHD death in women when evaluated as single
ECG variables and remained significant in multivariable-
adjusted risk models; (2) 2 sets were considered as candi-
dates for independent predictors of CHD death: Set 1, spatial
angles between Tpeak (Tp) and normal T reference (Tref)
vectors and between the initial and terminal T vectors (Ѳ(Tp|
Tref) and Ѳ(Tinit|Tterm), respectively), STJ depression in V6 and
rate-adjusted QTp interval (QTpa); and Set 2, TaVR and TV1
amplitudes, heart rate and QRS duration; (3) The strongest
independent predictors in women with and without CVD with
Table 3. Correlations Between Electrocardiographic Variables Selected for Evaluation of Independent Predictors of Coronary Heart
Disease Death
ECG Variables Ѳ(Tp|Tref) Ѳ(Tinit|Tterm) STJV6 QTpa TaVR TV1 Heart Rate QRS Duration
Ѳ(Tp|Tref)* 1.00
Ѳ(Tinit|Tterm)
† 0.30 1.00
STJV6‡ 0.30 0.17 1.00
QTpa
§ 0.09 0.07 0.10 1.00
TaVR 0.56 0.27 0.44 0.22 1.00
TV1 0.16 0.25 0.10 0.09 0.27 1.00
Heart rate 0.03 0.05 0.17 0.04 0.16 0.12 1.00
QRS duration 0.10 0.08 0.26 0.13 0.03 0.02 0.11 1.00
*Ѳ(Tp|Tref)=spatial angle between T peak (Tp) and normal T reference (Tref) vectors.
†Ѳ(Tinit|Tterm)=spatial angle between initial and terminal T vectors from the initial 3 and terminal 2 quintiles of repolarization, respectively.
‡STJV6=STJ-point amplitude.
§QTpa=rate-adjusted QT peak interval.
Table 4. Hazard Ratios With 95% Confidence Intervals for 2 Sets of Independent Predictors of CHD Death With Common Test
Group Cut-Off Points at 95th or 5th Percentiles in CVD-Free Women by CVD Status at Baseline
Variable (Cut Point)
CVD-Free Women Women With CVD
Model 1* Model 2* Model 1* Model 2*
Set 1
Ѳ(Tp|Tref) (>42°)
† 2.13 (1.72 to 2.64) 1.73 (1.36 to 2.21) 2.03 (1.68 to 2.46) 1.49 (1.20 to 1.87)
Ѳ(Tinit|Tterm) (>30°)
‡ 1.49 (1.19 to 1.86) 1.40 (1.08 to 1.80) 1.42 (1.14 to 1.75) 1.40 (1.11 to 1.78)
STJampl.V6 (<25 lV) 1.30 (1.00 to 1.67) 1.07 (0.79 to 1.44) 1.62 (1.32 to 1.98) 1.75 (1.39 to 2.20)
QTpa (≥360 ms)§ 1.49 (1.27 to 1.76) 1.37 (1.13 to 1.65) 1.29 (1.07 to 1.56) 1.23 (0.99 to 1.52)
Set 2‖
Tampl. aVR (>100) 2.27 (1.86 to 2.77) 1.81 (1.44 to 2.27) 2.09 (1.75 to 2.49) 1.71 (1.40 to 2.10)
Tampl. V1 (>175 lV) 1.56 (1.25 to 1.96) 1.41 (1.09 to 1.83) 1.85 (1.49 to 2.29) 1.54 (1.21 to 1.96)
Heart rate (>84/min) 2.25 (1.80 to 2.83) 1.78 (1.38 to 2.30) 1.30 (0.96 to 1.76) 1.14 (0.82 to 1.59)
QRS duration (≥100 ms) 1.64 (1.31 to 2.05) 1.35 (1.04 to 1.75) 1.45 (1.17 to 2.49) 1.45 (1.14 to 1.84)
CHD indicates coronary heart disease; CVD, cardiovascular disease.
*A set of ECG variables with low correlations (r<0.4) was entered simultaneously into the risk model, and each was adjusted for the other ECG variables with no further adjustment (Model 1)
and with additional adjustment for demographic and clinical factors (Model 2).
†Ѳ(Tp|Tref)=spatial angle between T peak (Tp) and T reference (Tref) vectors signifying deviation of repolarization direction in normal repolarization.
‡Ѳ(Tinit|Tterm)=spatial angle between the mean initial and terminal T vectors from quintiles 1 to 3 and 4 to 5, respectively.
§QTpa=rate-adjusted QT peak interval.
‖(Tp|Tref, Ѳ(Tinit|Tterm)) and STJ V6 were replaced in Set 2 by T amplitudes in aVR and V1.
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an over 2-fold increased risk were Ѳ(Tp|Tref) >42° in Set 1 and
TaVR amplitude less negative than 100 lV in Set 2;
(4) Among Set 2 variables also heart rate >84 had an over
2-fold increased risk in CVD-free women; (5) The risk for these
strong CHD death predictors remained significant after
multivariable adjustment for demographic/clinical factors;
and (6), Set 2 variable TaVR was as strong predictor as the
computationally more complex Set 1 best predictor Ѳ(Tp|Tref).
Possible Mechanisms for the Association of ECG
Predictors With the Risk of CHD Death
Three mechanisms possibly accounting for increased risk for
CVD death are summarized in Table 6. The first mechanism is
related to myocardial ischemia in chronic CHD. Myocardial
ischemia most commonly located in left-anterior-descending
coronary artery perfusion area shortens action potential
duration and alters spatial direction of the repolarization
sequence during the initial LV lateral wall repolarization. A
previous report from the Cardiovascular Health Study dem-
onstrated that anterior-right rotation of the Tp vector is
associated with QRS|T angle widening in CVD free men and
women.17 Anterior-right rotation of the Tp vector also
accounts for the increased (less negative) amplitude in aVR
and increased V1 amplitude (Figure 2). Thus, same patho-
physiological mechanisms relating to altered regional repo-
larization times may account for increased risk of CHD death
associated with Set 1 main predictor Ѳ(Tp|Tref) and Set 2
main predictor TaVR. The second mechanism in Table 6 is
related to LV overload in hypertensive heart disease. In LVH,
with increased epicardial excitation time (ETepi) and RTepi due
to increased LV mass and possibly also with slowed myocar-
dial conduction velocity leads into widening of Ѳ(Tp|Tref) and
Table 5. Hazard Ratios With 95% Confidence Intervals for CHD Death for Clinical and Related Electrocardiographic Findings in
Women With/Without CVD at Baseline
Clinical Classification
CVD Free Group (N=52 092) CVD Group (N=12 569)
Unadjusted Multivariable Adjusted* Unadjusted Multivariable Adjusted*
Hypertension (yes vs no)† 1.98 (1.73 to 2.26) 1.59 (1.36 to 1.87) 2.25 (1.89 to 2.68) 1.81 (1.43 to 2.30)
Diabetes (yes vs no)‡ 3.20 (2.66 to 3.86) 2.70 (2.20 to 3.31) 3.35 (2.80 to 4.01) 2.69 (2.16 to 3.36)
AF by self-report (yes vs no) 7.31 (3.28 to 16.3) 4.27 (1.86 to 9.79) 1.01 (0.83 to 1.24) 1.10 (0.86 to 1.39)
Ectopic complexes (yes vs no) 1.43 (1.09 to 1.89) 1.41 (1.03 to 1.94) 1.90 (1.45 to 2.47) 1.75 (1.28 to 2.38)
Left atrial enlargement (yes vs no)§ 1.61 (1.37 to 2.17) 1.24 (0.92 to 1.66) 1.94 (1.53 to 2.45) 1.59 (1.22 to 2.08)
AF at baseline ECG (yes vs no) — — 2.19 (1.46 to 3.26) 2.61 (1.62 to 4.20)
Major ST depression (yes vs no)‖ — — 2.76 (2.13 to 3.57) 2.10 (1.65 to 2.68)
ECG-LVH & ST-T (yes vs no)¶ — — 2.68 (1.96 to 3.67) 2.16 (1.53 to 3.05)
ECG-MI by MC (yes vs no)# — — 1.62 (1.33 to 1.98) 1.62 (1.29 to 2.03)
AF indicates atrial fibrillation; CHD, coronary heart disease; CVD, cardiovascular disease; ECG, electrocardiographic; MC, Minnesota code; MI, myocardial infarction.
*Multivariable single ECG variable model adjusted for age, ethnicity, body mass index, smoking status, hypertension, diabetes mellitus, CVD status at baseline, hypercholesterolemia,
family history of CHD, systolic blood pressure, heart rate, and study component/arm groups (hormone therapy/dietary modification/calcium and vitamin D).
†Hypertension defined as systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg or on medication for hypertension.
‡Diabetes defined as self-report of physician diagnosis and treatment with insulin or oral antidiabetic drugs.
§MC 9.6.
‖Major ST depression=MC 4.1 or 4.2.
¶ECG-LVH & major ST-T=Left ventricular hypertrophy by Cornell Voltage (RaVL+SV3) ≥2200 lV) & MC 4.1/4.3.
#MC 1.1/1.2 or MC 1.3 & MC 5.1/5.2.
Figure 2. T wave amplitude changes in leads aVR
(left) and V6 (right) with anterior-right rotation of
the T vector in the horizontal plane from the
direction in normal depolarization (Ref, blank white
columns) by 60, 90 and 120 degrees (orange,
purple and green columns, respectively). TV6
amplitudes decrease and TaVR amplitudes increase
progressively with increasing rotation of the
T vector to anterior-right.
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the repolarization sequence changes progressively from
normal predominantly reverse to predominantly concordant
with respect to depolarization sequence generating the so
called LV strain pattern. A predominantly concordant repo-
larization sequence results in increase (less negative) aVR
amplitude, again suggesting that widened Ѳ(Tp|Tref) angle and
decreased TaVR amplitude are produced by the same
pathophysiological mechanism. Increasing dyssynchrony of
depolarization 11,12 may in turn, lead into dyssynchrony of
ventricular relaxation with impairment of diastolic function.18
These ECG abnormalities are associated with increased risk of
CHD death and heart failure. The third mechanism postulated
is associated with derailed ionic channel dynamics due to
possible adverse effects of cardioactive drugs and a multi-
plicity of other factors inducing regional QT prolongation
(increased QTpa, RTepi) or diffuse global QT prolongation,
known to be associated with increased risk of CHD death,
including sudden cardiac death.
Ѳ(Tinit|Tterm) was the second spatial angle as a significant
predictor of CHD death. Ѳ(Tinit|Tterm) reflects increased
difference in the spatial direction of repolarization during
initial and terminal repolarization as a manifestation of a
widened, rounder T vector loop related to T wave complexity
which has been suggested as an indicator of subclinical
myocardial ischemia in asymptomatic adults.19
Relation of the Present Study With Previous
Investigations
The risk of CHD death in CVD-free men and women 45 to
65 years old was evaluated in a report from the Atheroscle-
rosis Research in Communities Study excluding men and
women with a history or clinical manifestations of CHD or
other CVD.3 ECG-based exclusions from the CVD-free group
included QRS duration 120 ms or longer or major Q waves by
Minnesota Code20 (MC 1.1). In women, independent predic-
tors of the risk of CHD death were (QRSm|Tm) and (Tp|Tref),
with a 2-fold increased risk for the former, and with a 1.7-fold
increased risk for the latter variable. QTea was an independent
predictor in men but not in women. A notable finding in the
Atherosclerosis Research in Communities Study was that the
risk levels for independent predictors for CHD death were
stronger in women than in men. In the present investigation Ѳ
(Tp|Tref) and Ѳ(Tinit|Tterm) were independent predictors of
CHD death in addition to heart rate. In the selection of CHD-
free women in the present study a more extensive set of ECG-
based exclusions were made, including ECG evidence of an
old MI, atrial fibrillation in baseline ECG, high-amplitude QRS
(Cornell voltage) with even minor T-wave abnormalities (MC
5.1 to 5.3) so that the repolarization measures used can be
considered as isolated independent predictors of CHD death.
A report from the Seven Countries Study in a male cohort
with no manifest cardiac diseases at baseline evaluated the
risk of CHD death for isolated inverted T waves with no other
codable ECG abnormalities.5 The risk of CHD death for
inverted T waves was over 3-fold in 5-year follow-up,
decreasing with the length of follow-up but still significant
at 40-year follow-up.
Laukkanen et al evaluated the association of isolated T
wave inversion and widened QTS|T angle with the risk of SCD
in a male cohort from a general Finnish population with a 20-
year follow-up.4 In a multivariable adjusted single ECG
variable model, T wave inversion and widened QRS|T angle
were both associated with an over 3-fold risk for SCD. QRS
duration from 110 to 119 ms was also a significant predictor
of SCD compared to men with QRS duration <110 ms. Anttila
et al, in another report from a nationally representative
sample of the general Finnish population of adult men and
Table 6. Main Parameters of the Repolarization Model Associated With Mechanisms Accounting for Increased Risk of CHD Death
Main Parameters of the Repolarization Model Plausible Mechanisms
Rate-adjusted QT peak interval QTpa 1. APDepi and RTepi shorten in chronic ischemic CHD most commonly in LAD
perfusion area, widen Ѳ(Tp|Tref) and induce abnormal T waves in left-lateral
and anterior-right chest leads and aVR (Figure 2) associated with increased
risk for CVD death (Table 4).
2. Prolonged LV overload in hypertensive heart disease slows myocardial
conduction velocity, increases ETepi and RTepi, widens Ѳ(Tp|Tref) and
repolarization sequence changes from normal predominantly reverse to
predominantly concordant with respect to depolarization sequence (LV strain
pattern); abnormalities associated with increased risk of CHD death and
heart failure.
3. Regional QT prolongation (increased QTpa, RTepi) or diffuse global QT
prolongation for any reason; associated with increased CHD death.
Rate-adjusted QT end QTea
Spatial T peak vector deviation
angle from normal reference
direction
Ѳ(Tp|Tref)
LV epicardial excitation time ETepi;
ETepi=QR peak time
LV epicardial repolarization time;
Derived from QTpa, modified
by Ѳ(Tp|Tref)
RTepi
LV epicardial action potential
duration
APDepi;
APDepi=RTepiETepi
APD indicates action potential duration; CHD, coronary heart disease; CVD, cardiovascular disease; LV, left ventricle.
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women, documented that a positive T wave in aVR was a
strong predictor of CVD death in fully adjusted risk models.7
TaVR was also reported in an earlier study to be a predictor of
CVD death in a large clinical male population.21
Clinical Implications
Ѳ(Tp|Tref) was a strong predictor of CHD death in women with
CVD as well as in CVD-free women. From a practical clinical
point of view, a potentially more important observation was
that ECG variables such as TV1 and TaVR amplitudes (from
the alternative Set 2 in Table 4) were practically as strong
predictors of CHD death as the computationally more
complex angular measures of deviant repolarization. This
finding suggests that these simple variables may be poten-
tially useful clinical tools for identification of high-risk women
for preventive intervention on CHD death.
Limitations of the Study
Data were not available from echocardiographic evaluation of
cardiac function to permit a more refined identification of
silent CVD. T waves, particularly in women, are considered to
be sensitive to variations in sympathetic tone as reflected by
increased heart rate. However, the correlations between
heart rate and the angular measures of deviant spatial
direction of repolarization and also QTpa were low (r<0.4).
Since the primary focus of our study was on a limited
number of independent predictors of CHD death, no
provision was made to adjust for multiple comparisons for
mean differences between CVD and CVD-groups. No com-
peting risk analysis was done to evaluate additional risk of
CHD death for ECG variables beyond the risk information
contained in diabetes, hypertension, and other clinical
conditions. The primary aim of our study was not diagnostic
discrimination but rather an exploratory analysis to establish
associations as the first-line predictors of CHD death and to
consider possible mechanisms accounting for the observed
excess risk found for them.
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